Quick Answer
Quince Therapeutics, Inc. reported Net Income of -$56.83 million for fiscal year 2024.
Quince Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$56.83M | -81.1% |
| 2023 | -$31.39M | +39.2% |
| 2022 | -$51.66M | +42.6% |
| 2021 | -$89.94M | -17.0% |
| 2020 | -$76.85M | -107.8% |
| 2019 | -$36.98M | -196.4% |
| 2018 | -$12.48M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.44M | -144.8% | +16.2% |
| June 30, 2025 | -$16.05M | +42.1% | -6.8% |
| March 31, 2025 | -$15.03M | -34.8% | -173.7% |
| September 30, 2024 | -$5.49M | -2.6% | +80.2% |
| June 30, 2024 | -$27.73M | -467.5% | -148.7% |
| March 31, 2024 | -$11.15M | +9.0% | -108.4% |
| September 30, 2023 | -$5.35M | +32.4% | -9.5% |
| June 30, 2023 | -$4.89M | +70.5% | +60.1% |
- Quince Therapeutics, Inc. showed a decrease of -81.1% in Net Income compared to the prior fiscal year.
- Over the 2018–2024 period, Quince Therapeutics, Inc.’s net income has declined by 355.5% (from -$12.48 million to -$56.83 million).
- The most recent figure is from Quince Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: